glp-1 sparks SURGE IN DRUGS LIKE OZEMPIC THOUSANDS OF LAWSUITS OVER ALLEGED SIDE EFFECTS The medications, initially for type 2 diabetes, have driven widespread off-label weight-loss use amid reported gastrointestinal injuries and 000+ patients and transform your health Serena Williams Ad Sparks Demand

Eat mindfully: Smaller, balanced meals support medication effectiveness

Marys Hospital, The Catholic University of Korea) to evaluate the safety, tolerability, and pharmacokinetics of subcutaneous PG-102 in healthy individuals with overweight (body mass index 2530 kg/m), with exploratory pharmacodynamic and biomarker assessments

[DOI] [PMC free article] [PubMed] [Google Scholar] 47.Park HC, Lee YK, Cho A, et al

Liang, Q

10.1677/JOE-08-0468

Food & Drug Administration, Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity (2024)